Jc. Rubio et al., CEREBROSPINAL-FLUID CARNITINE LEVELS IN PATIENTS WITH ALZHEIMERS-DISEASE, Journal of the neurological sciences, 155(2), 1998, pp. 192-195
We assessed free carnitine (FC) and acylcarnitine esters (AC) in both
cerebrospinal fluid (CSF) and plasma from 24 patients with diagnostic
criteria for Alzheimer's disease (AD), and from 28 healthy matched-con
trols. We found no significant correlation between FC and AC levels in
CSF. FC and AC levels in CSF did not differ significantly between AD
patients and controls, but plasma FC levels were significantly lower i
n AD patients. CSF and plasma FC and AC levels did not correlate with
age, age at onset of AD, duration of AD, and scores of the Minimental
State Examination of Folstein. Although these results suggest that CSF
carnitine levels are apparently unrelated with the risk for AD, the t
rend of the FC/AC ratio to be higher in AD patients might suggest the
possibility of a lower carnitine acetyltransferase activity in AD, as
previously reported in some brain areas. (C) 1998 Elsevier Science B.V
.